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treated with b/fEVAR at Uppsala University Hospital 2010 e2015. Patient
records and administrative data were examined to assess health care re-
sources used and material cost. Cost and resources for all adjunctive pre-
paratory procedures (such as access operation, debranching, and staged
aortic procedures) as well as all related post-operative procedures (such as
extension and relining of stent grafts) were included in the analysis.
Results: A total of 56 patients were included (19 women), mean age 72
years (range 52e83), average aneurysm size 62 mm (range 36e98). The
patients were ASA class 2 (n ¼ 11), 3 (n ¼ 36) and 4 (n ¼ 9). Pre-operative
risk factors included cardiac (n ¼ 31), pulmonary (n ¼ 22), cerebrovascular
(n ¼ 8), renal disease (n ¼ 5) and previous aortic surgery (n ¼ 17).
Aneurysm types were TAAA type I n ¼ 1, II n ¼ 10, III n ¼ 4, IV n ¼ 9,
JPRAA n ¼ 32. Treatment was performed with f-EVAR n ¼ 38, b-EVAR
n ¼ 12 and f/b-EVAR n ¼ 6. Mortality was 3.6% at 30 days (TAAA 4.2%,
JPRAA 3.1%) and 19% at 1 year (TAAA 33.3%, JPRAA 8.3%). Post-operative
complications included cardiac event (n ¼ 7), cerebrovascular event (n ¼ 5,
4 permanent), renal impairment (n ¼ 6, 4 permanent), paraplegia (n ¼ 4, 1
permanent), and graft-occlusion (n ¼ 4, 3 symptomatic). Median total
hospital-stay (for all procedures) was 26 days (range 2e114) for TAAA and 8
days (2e50) for JPRAA. Median time spent in ICU was 0.9 days (0e42) for
TAAA and 0 days (0e43) for JPRAA. Median operating time for the main
procedure was 464 minutes (101 e1025) for TAAA and 273 minutes (62e
677) for JPRAA, and for the adjunctive procedures was 97 minutes (10 e
734) for TAAA, and 0 minutes (0e1609) for JPRAA. The estimated total cost
for hospital stay, intensive care, anaesthesiology, surgeries and materials
was 117971 V for TAAA and 63362 V for JPRAA. Average material cost
including stent grafts was 34625V for TAAA, and 23732V for JPRAA.
Conclusion: Endovascular treatment of complex aortic aneurysms re-
sults in acceptable clinical outcome, but is associated with high cost and
resource utilisation. Stent grafts and material stand for 1/3 of the treat-
ment cost in these patients.
Long-term Results of Iliofemoral Revascularizations in High-
performance Athletes.
P. Feugier, O. Rouviere, N. Della Schiava, A. Millon, P. Lermusiaux,
J.M. Chevalier
University Claude Bernard Lyon 1, France
Introduction: Evaluation of clinical and sports results of surgical treatment
of iliofemoral arterial occlusive lesions. Long-term follow up of an operated
high level athlete cohort.
Methods: From 1991 to 2013, 56 women and 435 men (mean
age ¼ 34  11 years) were operated on for a symptomatic iliofemoral
arterial occlusive disease in a single vascular institution. They were 26
professional athletes, 235 amateur competitors and 230 amateurs. 427
were cyclists (87%), 38 were triathletes (8%), 23 were long-distance run-
ners (5%) and 3 were practicing another sport. Bilateral surgery was per-
formed in 43 patients (8.7%). Pain during supra-maximal exercise, limb
claudication and sub-acute ischemia were diagnosed in 475 (89%), 47 (9%)
and 12 cases (2%) respectively. External iliac artery lesions were the most
frequent (428 lesions, 67%). Locations were multiple in 103 cases (19% of
procedures). The surgical indications were: a stenotic endoﬁbrosis in 463
cases (87%), a native iliac thrombosis in 37 cases (7%), an unsuccessful
endoﬁbrosectomy or bypass performed in another center in 34 cases (6%).
The surgical procedure consisted of an endoﬁbrosectomy with patch in 332
cases (62%), a venous calibrated iliofemoral bypass in 202 cases (38%). 10
iliac PTA without stenting, prior to the optimal surgical treatment (average
delay of 4.2 months) were performed, with the aim ﬁnishing sports season.
An antiplatelet therapy was prescribed for 6 months or for life. Medical
data and duplex-scan follow ups were kept prospectively in a database and
analyzed.
Results: A 28 years-old professional patient died three weeks after an
endoﬁbrosectomy, of iliac rupture because he retrained too early. A post-
operative thrombosis required an iliac thrombectomy in 11 cases. This
procedure was associated 1 times with a popliteal thrombectomy. 26 pa-
tients were lost to follow up within 3 years. The mean follow up was
15.7  7.5 years. Sport resumption was possible in 97%. The mean delayfor athletic recovery was 3.2  1.5 months. Long-term athletic perfor-
mances were improved at 3, 5 and 7 years, 97%, 95% and 91% respectively.
Iliac revascularization, endoﬁbrosectomy and iliofemoral bypass primary
actuarial patencies were at 3, 5 and 10 years: 97%, 96%, 94%/96%, 94%,
92%/98%, 98% and 95% respectively. Secondary patencies were 100%. No
predictive factor of failure was found.
Conclusion: The long-term beneﬁts of iliofemoral revascularizations are
good. They validate surgical indications. However, a sports rehabilitation
protocol and a strict selection of the indications must be further conﬁrmed.
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Introduction: To investigate renal outcomes following endovascular repair
of thoraco-abdominal aneurysms (TAAA) with renal fenestrated or
branched endografts.
Methods: Renal outcomes following TAAA endovascular repair per-
formed with renal branches were collected in 5 European high volume
centers and compared with renal outcomes following TAAA endovascular
repair performed with renal fenestrations. Renal re-intervention and oc-
clusion rates and freedom from any renal outcome and death were
analyzed per-patient and per-target vessel.
Results: 449 patients were included in this retrospective study (235
treated with branched devices (BEVAR) and 214 with fenestrated devices
(FEVAR)). 841 renal vessels were analyzed (436 perfused by branches and
411 by fenestrations). Both groups were comparable except for sex,
smoking habit and anti-vitamin K treatment. Technical success rate was
98.7% and 99.1% respectively.
The mean follow up was 19.2 months (SD 18.2) after BEVAR and 24.3
months (SD 20.6) after FEVAR. During follow up, renal re-intervention rates
were similar in both groups (4.7% vs. 5.2%). The renal occlusion rate was
signiﬁcantly higher following BEVAR (9.4% vs. 2.3%, P ¼ 0.002), and the 2-
year freedom for renal occlusion rate was 94.4% (SE, 92.2%-96.6%)
following BEVAR and 98.9% (SE, 98.1%-99.7%) following FEVAR
(P < 0.001). The 2-year survival rate was 73.4% (SE, 69.8%-77%) and
80.7% (SE, 77.4%-84%) following BEVAR and FEVAR respectively.
Conclusion: Mid-term renal outcomes following endovascular repair of
TAAA are satisfactory. Endograft designs incorporating renal fenestrations
rather than renal branches are associated with signiﬁcantly improved mid-
term patency rates.
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Introduction: Following the pioneering experience and the initial learning
curve, we evaluated the subsequent results in 3 aortic endovascular cen-
tres with signiﬁcant experience (>10 cases) with this new technique.
Methods: Between April 2013 and November 2014, all patients with
arch aneurysms >55 mm deemed unﬁt for open surgery after multidisci-
plinary evaluation, and treated with 2 inner branches endografts, were
included. Inner branches were designed to perfuse the brachiocephalic
trunk and the left common carotid artery (LCC) in all cases. According to
reporting standards, technical success, endoleaks, procedure length, ﬂuo-
roscopy duration and contrast volume injected, early and late complica-
tions and mortality were retrospectively collected in a unique electronic
database.
Results: Twenty-seven patients were included and treated for arch an-
eurysms (70%) or chronic dissections (30%). Technical success was always
achieved. No patients died during the 30 day post-operative period. Early
Abstracts 395neurologic events included 2 major and one minor stroke (11%). Transient
spinal cord ischemia with full recovery was observed in 2 patients (7%). One
myocardial infarction required medical treatment (4%) and 2 renal function
impairment (7%) were depicted. Early (<30 day) re-interventions (11%)
were performed to treat one access complication, one left ventricle false
aneurysm suspicion and one limb ischemia. During follow up (median 12
months), 1 patient (4%) died from a remote TAAA rupture. Two type 2 (7%)
and one type 3 endoleaks (4%) were depicted. During follow up, 2 (7%) re-
interventions were performed to treat the type 3 endoleak and a septic
aortic false aneurysm.
Conclusion: The outcomes associated with this new technique are
favourable when the procedure is performed in experienced centres.
Branched endografting of arch aneurysms should be considered in patients
unﬁt for open surgery.
Long-term Survival after TEVAR depends on Indication for
Surgery, and is Shorter than Expected after Ruptured Thoracic
Aneurysm
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Introduction: Thoracic endovascular aortic repair (TEVAR) is used in
treatment of type B aortic dissections and descending aortic aneurysms
increasingly often. TEVAR is associated with lower peri-operative mortality
when compared to open surgery in retrospective studies. We assessed
long-term survival after TEVAR depending on diagnosis.
Methods: All patients who underwent TEVAR for type B aortic dissec-
tion or thoracic aortic aneurysm at Uppsala University Hospital between
December 1999 and December 2013 were included. Traumatic aortic
transections, thoraco-abdominal- and mycotic aneurysms, as well as type A
dissections were not included. Patient characteristics and survival data
were collected from medical records. 30 day survival was analyzed with
chi2 and 5 year survival was estimated with Kaplan-Meier. Age-adjusted
survival was estimated with a Cox regression analysis.
Results: Of the 250 patients who underwent TEVAR, 190 were included
(excluded: traumatic transections n ¼ 17, thoraco-abdominal hybrid pro-
cedures n ¼ 20, mycotic aneurysms n ¼ 5, type A dissections n ¼ 8, others
n ¼ 10). Diagnosis distribution was acute type B aortic dissection (ABAD)
n¼ 63; chronic typeB aortic dissection (CBAD) n¼ 45; intact aneurysm (iTAA)
n ¼ 57 and ruptured aneurysm (rTAA) n ¼ 25. Mean follow up was 49
months. Mean age of the patients was ABAD 66.5 years; CBAD 61.9; iTAA
71.6; rTAA 74.5 (p< 0.001).The male to female ratio was ABAD 41:22; CBAD
34:11, iTAA 34:23, rTAA 12:13 (p¼ 0.132). 30 day survival was ABAD 92.1%;
CBAD 95.6%; iTAA 96.5%; rTAA 72.0% (p¼ 0.002). 5 year survival was ABAD
79.2%; CBAD 79.6%; iTAA 66.0%; no patient with 5 year follow up after rTAA
was alive, and 3 year survival was 30.8%, see attached ﬁgure (Log-Rank
p< 0.001). In a Cox regression analysis of mid-term survival for patients who
survived the initial 30 day peri-operative period, age-adjusted hazard ratio for
death was 5.7 after rTAA compared to the other diagnoses.
Conclusion: Long-term survival after TEVAR was adequate for patients
with type B aortic dissection and intact aortic aneurysm. Considering the
poor long-term survival after TEVAR for ruptured aortic aneurysm, it may
be necessary to be more selective when deciding which of these patients
who beneﬁt from active treatment.
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Introduction: Renal failure is a signiﬁcant source of morbidity and mortality
in patients who require thoraco-abdominal (TAA) aortic repair. We
reviewed our 25 year experience with open descending thoracic and
thoraco-abdominal repair to identify risk factors for and potential thera-
peutic targets to prevent renal failure.Methods: We performed 1896 operations in 1795 patients. The ma-
jority of cases were performed using cerebrospinal ﬂuid drainage and
distal aortic perfusion, and visceral perfusion was used selectively in
patients with repairs that involved the origins of the celiac, superior
mesenteric and renal arteries. Renal failure was deﬁned as new-onset
renal dysfunction in patients without existing chronic renal disease, and
included an increase in post-op creatinine >1 mg/dl/day over the ﬁrst
two post-op days, an absolute creatinine >4 mg/dl or need for dialysis.
Multivariable statistics were used to assess pre-and intra-operative risk
factors for renal dysfunction, and the effect of renal morbidity on long-
term survival was evaluated by Kaplan-Meier analysis.
Results: Mean population age was 64.2 +/- 13.9, and 669/1795 (37%)
patients were female. Renal dysfunction occurred after 488/1896 (25.7%)
operations. Multivariable pre-operative predictors of post-operative renal
failure were patient age (OR 1.03/yr, p < 0.0001), TAA extent 1 (OR 2.02,
p < 0.0001), TAA2 (OR 5.9, p < 0.0001), TAA3 (OR 4.2, p < 0.0001), TAA4
(OR 2.9, p < 0.0001), emergency presentation (OR 1.4, p < 0.04) and
coronary artery disease (CAD; OR 1.3, p < 0.04). Addition of intra-operative
variables identiﬁed patient age (OR 1.03/yr, p < 0.0001), aortic dissection
(OR 0.62, p < 0.002), involvement of the aortic segment containing the
visceral vessel origins (OR 1.5, p < 0.005), COPD (OR 1.3, p < 0.02), aortic
cross clamp time (OR1.02/min, p < 0.0001), and PRBC use (OR 1.04/unit,
p < 0.0001). Visceral perfusion was associated with modestly increased risk
(OR 1.3, p < 0.04) among patients with aneurysm extents (TAA 1, 2, and 4)
involving the visceral vessels. Incidence of renal dysfunction has risen
gradually over time. Long-term survival is strongly inﬂuenced by post-
operative renal failure (Figure, p < 0.0001).
Conclusion: New-onset renal dysfunction is common after thoraco-
abdominal aortic surgery, and is strongly associated with reduced long-
term survival. Renal protection strategies are urgently needed, and treat-
ments that can reduce the effects of ischemic time and transfusion are
likely intervention targets.
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Introduction: Endovascular repair of thoraco-abdominal aneurysms with
branched stent grafts (bEVAR) has shown promising results in the elec-
tive situation. Off the shelf devices have been introduced recently
allowing endovascular treatment of TAAA in the acute setting, including
rupture (rTAAA). However, very little is known about acute bEVAR for the
treatment of rTAAA. Our aim is to report the results of acute bEVAR in
patients with rTAAA.
Methods: A retrospective review of patients undergoing acute bEVAR
between 2008 and April 2015 in a single centre with large experience of the
elective procedures. Stent grafts used consisted mostly of off the shelf
endograft with 4 caudally oriented branches. Spinal drainage use was
decided depending on the emergency character of the operation. Values
are presented as median and range when not stated otherwise.
Results: 10 patients, (5 males, 64 (34e77) years old) underwent
bEVAR during the study period. TAAA had a median pre-operative
diameter of 70 (57- 90) mm and the anatomy according to Crawford was:
2 type I, 4 type II, 3 type III and 1 type IV. Median operative time was
436 (245e785) minutes. Endovascular conduit had to be used in 2 pa-
tients. Six patients had all 4 visceral arteries incorporated in the repair
while 2 and 1 patient had 3 and 2 arteries, respectively. One patient died
intra-operatively before the branches could be extended, making the
immediate technical success 90 % (n ¼ 9). Two more patients died within
30 days of bEVAR (30 day mortality of 30 %). Four of the nine patients
surviving bEVAR (44%) developed signs of post-operative spinal cord
ischemia. Three of the patients recovered completely while one devel-
oping the symptoms 4 days after bEVAR remained paraplegic. The 7
patients surviving more than 30 days were followed-up for 13 (1 e38)
months). During this period only one patient died of unrelated causes.
During the CT follow up (median of 13 (1e38) months) no aneurysms
expanded. One patient underwent an arch repair 9 months post-
